MYDA Advisors’s Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share FVIV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-12,400
Closed -$10K – 349
2021
Q3
$10K Buy
+12,400
New +$13.5K ﹤0.01% 260

Other funds holding FVIV.WS

MYDA Advisors's FVIV.WS Position: Q4 2021 in Review

MYDA Advisors sold out of Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (FVIV.WS) in Q4 2021, closing a stake of 12,400 shares — an estimated $10K sold.

MYDA Advisors first reported a position in FVIV.WS in Q3 2021 and held it in 1 quarter. The position peaked at $10K in Q3 2021. 52 funds tracked by Wall St. Rank hold FVIV.WS as of Q4 2021.

  • MYDA Advisors reported no remaining Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
  • MYDA Advisors sold 12,400 Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q4 2021, an estimated $10K.
  • MYDA Advisors first reported a position in Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q3 2021 and held it in 1 quarter.
  • MYDA Advisors's Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $10K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q4 2021.

Based on MYDA Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.